ProSomnus Stock (NASDAQ:OSA)


RevenueOwnershipFinancialsChartTranscripts

Previous Close

$0.47

52W Range

$0.10 - $5.15

50D Avg

$0.53

200D Avg

$0.81

Market Cap

$8.18M

Avg Vol (3M)

$64.05K

Beta

0.21

Div Yield

-

OSA Company Profile


Prosomnus Sleep Technologies, Inc. designs, manufactures, and markets sleep apnea therapy devices for dentists to treat patients diagnosed with obstructive sleep apnea. The company was incorporated in 2016 and is based in Pleasanton, California.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

136

IPO Date

Jul 28, 2021

Website

OSA Performance


OSA Financial Summary


Dec 23Dec 22Dec 21
Revenue$27.65M$19.39M$14.07M
Operating Income$-19.11M$-1.03M$-4.81M
Net Income$-24.09M$3.30M$-5.98M
EBITDA$-16.89M$-11.48M$-3.99M
Basic EPS$-1.49$0.21$-0.37
Diluted EPS$-1.49$0.21$-0.37

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q4 23Mar 27, 24 | 12:15 AM

Peer Comparison


TickerCompany
ANIKAnika Therapeutics, Inc.
IRMDIRadimed Corporation
OFIXOrthofix Medical Inc.
ITGRInteger Holdings Corporation
LUNGPulmonx Corporation
NPCENeuroPace, Inc.
SRDXSurmodics, Inc.
LIVNLivaNova PLC
KIDSOrthoPediatrics Corp.
AORTArtivion, Inc.
ESTAEstablishment Labs Holdings Inc.
CVRXCVRx, Inc.
CNMDCONMED Corporation